-+ 0.00%
-+ 0.00%
-+ 0.00%

AVITA Medical Sees Q4 Sales $24.900M-$26.900M vs $23.800M Est

Benzinga·11/05/2026 21:10:45
Listen to the news
AVITA Medical (NASDAQ:RCEL) sees Q4 sales of $24.900 million-$26.900 million vs $23.800 million analyst estimate.